79
67
Growth Score
-8 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
497667
Cellis develops cell-based therapies for oncology, focusing on therapeutic macrophages to treat solid tumors.
- Magdalena Król: Co-Founder and CSO
- Tomasz Rygiel: Co-Founder, CTO and Member of the Board
About the Company
Cellis is a biotechnology company focused on developing innovative cell-based therapies for oncology. With a commitment to advancing cancer treatment, Cellis has pioneered a platform technology centered around therapeutic macrophages designed to combat solid tumors. This approach aims to transform the tumor microenvironment, leveraging the
body's immune system to fight cancer more effectively. The company's research and development efforts are dedicated to creating solutions that address the complexities of the tumor microenvironment, offering potential new avenues for oncology treatment.
